Large-scale production of a TACI-targeting antibody to test its therapeutic efficacy in a preclinical model of chronic lymphocytic leukaemia.

Read full text
Authors: Therapeutic Innovation Australia
Cited by: 0

Fields of Study & Subjects

Chronic Lymphocytic Leukemia Research Monoclonal and Polyclonal Antibodies Research Lymphoma Diagnosis and Treatment

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN